Clinical Trial Update: FM101 Safety, Tolerability, Efficacy Study in the Patients With Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

A safety, tolerability, and efficacy study (Phase 1/2) of FM101 in patients with ocular hypertension is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension

Drugs mentioned

• FM101

Snippet

Sponsor: Future Medicine | Conditions: Ocular Hypertension | Phase 1, Phase 2 | Status: UNKNOWN